Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - heparin sodium - solution for injection - 1000unit/1ml

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - heparin sodium - solution for injection - 5000unit/1ml

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - heparin sodium - solution for injection - 5000unit/1ml

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - heparin sodium - solution for injection - 25000unit/1ml

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - heparin sodium - solution for injection - 25000unit/1ml

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - suxamethonium chloride - solution for injection/infusion - 50 milligram(s)/millilitre - choline derivatives; suxamethonium

Malta - anglès - Medicines Authority

aspen pharma trading limited 3016 lake drive city west businees campus dublin 24, ireland - suxamethonium chloride - solution for injection/infusion - suxamethonium chloride 50 mg/ml - muscle relaxants

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - calcium chloride dihydrate, quantity: 36 micromole/ml; human thrombin, quantity: 400 iu/ml - solution - excipient ingredients: albumin; sodium chloride; water for injections - tissel is indicated: - as adjunct to haemostasis during surgical procedures, when control of bleeding by conventional surgical techniques is ineffective or impractical; and - as a sealant as an adjunct for closure of colostomies. - as a sealant and/or adhesive for use in autologous chrondrocyte implantation (aci) or matrix-induced autologous chondrocyte implantation (maci) procedures. - for mesh fixation in non-iatrogenic abdominal wall hernia repair, as an alternative to sutures, staples or tacks.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - aprotinin 2250 kiu/ml - 3750 kiu/ml; factor xiii 1.2 iu/ml - 10 iu/ml; fibrinogen 72 mg/ml - 110 mg/ml; calcium chloride dihydrate 0.036 mmol/ml - 0.044 mmol/ml; thrombin 3.2 iu/ml - 5 iu/ml - topical solution - 4 iu - active: aprotinin 2250 kiu/ml - 3750 kiu/ml factor xiii 1.2 iu/ml - 10 iu/ml fibrinogen 72 mg/ml - 110 mg/ml excipient: albumin histidine nicotinamide polysorbate 80 sodium citrate dihydrate water for injection active: calcium chloride dihydrate 0.036 mmol/ml - 0.044 mmol/ml thrombin 3.2 iu/ml - 5 iu/ml excipient: albumin sodium chloride water for injection - artiss is indicated for use in adhering autologous skin grafts in burn patients. artiss is not indicated for haemostasis.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - aprotinin, quantity: 10000 kiu/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - trasylol is used prophylactically to reduce perioperative blood loss and to reduce the need for blood transfusion in adult patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery, where the risk of bleeding is high (impaired haemostasis, eg. presence of aspirin) or where transfusion is unavailable or unacceptable.